Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials

• Published in: The American journal of clinical nutrition Vol. 100; no. 6; pp. 1413 - 1421
• Main Authors: Whitehead, Anne, Beck, Eleanor J, Tosh, Susan, Wolever, Thomas MS
• Format: Journal Article
• Language: English
• Published: United States American Society for Clinical Nutrition 01.12.2014; American Society for Nutrition
• Subjects: Avena - chemistry; beta-glucans; beta-Glucans - administration & dosage; blood serum; cholesteremic effect; Cholesterol, HDL - blood; Cholesterol, LDL - blood; clinical nutrition; diabetes; diet; Dietary Fiber - administration & dosage; health claims; high density lipoprotein cholesterol; Humans; Lipids; low density lipoprotein cholesterol; meta-analysis; oats; Plant Extracts - administration & dosage; randomized clinical trials; Randomized Controlled Trials as Topic; soluble fiber; triacylglycerols; Triglycerides - blood; triglyceride; β-glucan; oats; meta-analysis; LDL cholesterol; total cholesterol; HDL cholesterol

Background: Health claims regarding the cholesterol-lowering effect of soluble fiber from oat products, approved by food standards agencies worldwide, are based on a diet containing ≥3 g/d of oat β-glucan (OBG). Given the number of recently published randomized controlled trials (RCTs), it is import...